Vinva Investment Management Ltd
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1968109
SYDNEY, C3
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,651,221
+$34,541,049 QoQ
Shares Held
154,972
+323.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#90
of 786 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vinva Investment Management Ltd holds $143,806,233 across 13 Biotechnology names. ALNY ranks #2 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
462,843 | $52,467,882 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
154,972 | $46,651,221 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
34,494 | $21,508,388 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,687 | $15,243,153 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
24,835 | $1,943,835 | |
| 6 | EXEL |
Exelixis, Inc.
|
31,102 | $1,692,259 | |
| 7 | ASND |
Ascendis Pharma A/S
|
4,536 | $1,209,841 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
19,569 | $1,119,738 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,651,221 | 154,972 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,110,172 | 36,601 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,142,191 | 17,961 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $573,648 | 1,258 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||